Clinical Trial

MRI (Imaging Scan) of Breast Tissue

Study Description

Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study

The purpose of this study is to evaluate potential clinical efficacy of a novel magnetic resonance imaging (MRI) approach, MR fingerprinting, capable of providing quantitative measures of important tissue properties, which could provide important insights into normal breast tissue. This new MRI sequence will be added to the screening breast Dynamic Contrast Enhanced (DCE) MRI for high risk normal patients.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - MR Fingerprinting

The MR fingerprinting technique requires less than 15 minutes total and will be added before and after the standard MRI sequence.

Additional Information

Official Study Title

Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study

Clinical Trial ID

NCT03846947

ParticipAid ID

e0RoVb